Labshake search
Citations for Tocris :
851 - 900 of 1228 citations for RGPD1 2 3 4 5 8 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... where N2 medium was supplemented with SB431542 (5 µM, Tocris, 1614), XAV939 (1 µM ...
-
bioRxiv - Cell Biology 2021Quote: ... 10 μl dilution buffer containing 5 μM A-485 (Tocris, 6387) were added and reaction allowed to equilibrate at room temperature for 10 min ...
-
bioRxiv - Neuroscience 2022Quote: ... cells were incubated for 1 h with 5 µM GsMTx4 (Tocris) or 15 and 30 min with 1 µM soluble Aβ1-42 (Bachem ...
-
bioRxiv - Neuroscience 2022Quote: ... where N2 medium was supplemented with SB431542 (5 μM, Tocris, 1614), XAV939 (1 μM ...
-
bioRxiv - Cell Biology 2023Quote: ... For drug treatments: AACOCF3 (selective phospholipase A2 inhibitor, Tocris #1462-5), CK666 (selective Arp2/3 inhibitor ...
-
bioRxiv - Neuroscience 2023Quote: ... and Clozapine N-oxide dihydrochloride (CNO, 5 mg/kg, Tocris Bioscence) were dissolved in sterile 0.9% NaCl (saline) ...
-
bioRxiv - Neuroscience 2024Quote: ... was dissolved in 5% DMSO (Tocris Bioscience, Cat#: 3176; Batch: 68A) containing PBS (Corning ...
-
HOIL-1L deficiency induces cell cycle alteration which causes immaturity of myocyte and fibrogenesisbioRxiv - Cell Biology 2023Quote: ... The medium was supplemented with 5 μM Y27632 (TOCRIS, Cat.# 1254), a Rho-associated kinase inhibitor ...
-
bioRxiv - Neuroscience 2021Quote: Varenicline or 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h] [3]benzazepine tartrate (Tocris, UK) was dissolved in sterile 0.9% physiological saline for a final dose of 1 mg/kg free base ...
-
bioRxiv - Neuroscience 2021Quote: ... some slices were incubated at 37°C with 3 µM puromycin (Tocris #40-895-0) at 65-75 minutes post-slicing ...
-
bioRxiv - Neuroscience 2022Quote: ... with the addition of either 3 μM or 10 mM GABA (Tocris; Cat. No. 0344). Sylgard 184 (Dow Corning ...
-
bioRxiv - Neuroscience 2021Quote: AM251 pharmacology: in experiments using the CB1 antagonist AM251 (3 µM) (Tocris and AdooQ biosciences), the drug (diluted in DMSO ...
-
bioRxiv - Neuroscience 2020Quote: ... with either 3 mg/kg clozapine N-oxide (CNO; Tocris, Catalog: 4936, Lot: 13D/233085) in 0.5% DMSO and saline ...
-
bioRxiv - Neuroscience 2022Quote: ... mEPSCs were recorded in the presence of 3 μM AMPA receptor antagonist NBQX (Tocris Bioscience) in standard external solution.
-
bioRxiv - Cell Biology 2023Quote: ... the CDBM medium was supplemented with 0.6 U/ml heparin and 3 mM IWP2 (Tocris) for another 3-day incubation with medium refreshed daily ...
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247; 5 μM SR-95531, Tocris, 1262; 1 μM CGP-55845, Tocris, 1248) were included in the recording solutions.
-
bioRxiv - Neuroscience 2019Quote: ... 4-methoxy-7-nitroindolinyl-caged L-glutamate (MNI-glutamate) were purchased from Tocris Cookson (UK) ...
-
bioRxiv - Immunology 2021Quote: ... The non-selective MIF family cytokine inhibitor 4-IPP was obtained from Tocris Bioscience.
-
bioRxiv - Cancer Biology 2023Quote: ... The N2/B27 medium was supplemented with 4 µM Dorsomorphin (Tocris, Cat # 3039) and 10 µM SB431542 (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... MNI-glutamate (4 methoxy-7-nitroindolinyl caged L-glutamate) was purchased from Tocris Bioscience ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 50 ng/mL bone morphogenetic protein 4 (BMP4; Tocris; 314-BP) and 100 ng/mL activin A (Tocris ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 50 ng/mL bone morphogenetic protein 4 (BMP4; Tocris; 314-BP) and 100 ng/mL activin A (Tocris ...
-
bioRxiv - Cell Biology 2020Quote: ... Macrophages were treated with MLi-2 (Cat# 5756/10, Tocris) at 0.1 μM for 1 h before treatment with LLOMe where indicated ...
-
bioRxiv - Bioengineering 2022Quote: ... resuspended in E8 Flex medium with 2 μM Thiazovivin (Tocris) at 100,000 cells/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... Stocks of the kinase inhibitor MLi-2 (10 mM; Tocris) were stored in DMSO at −20°C.
-
bioRxiv - Biochemistry 2020Quote: ... and plate blocked with 300 µL 2% BSA (#5217, Tocris) in 1xPBS for 1 hour at room temperature ...
-
bioRxiv - Neuroscience 2020Quote: ... GSK-2578215A (#4629) and MLi-2 (# 5756) were from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2021Quote: ... coiled-coil containing protein kinase (ROCK1/2) Y27632 (Tocris, Inc.) at 10 µM in PBS for 1-2 hr ...
-
bioRxiv - Neuroscience 2022Quote: ... and ascorbic acid (100 µL, 2 mM, Tocris Bioscience, 4055). Synaptojuice B medium was filtered through a 0.22-µm filter ...
-
bioRxiv - Neuroscience 2022Quote: ... CU-T12-9 (TLR1/2 agonist; 2.5ug/dose; Tocris; 5414), CU-CPT22 (TLR antagonist ...
-
bioRxiv - Neuroscience 2020Quote: ... GABA (10 μM, Tocris, #A5835-25G, CAS: 56-12-2), bafilomycin (4 μM ...
-
bioRxiv - Cell Biology 2020Quote: ... Torin 1 (Tocris, 4247, 250 nM in DMSO, 2 hrs), Bortezomib (LC Labs B-1408 ...
-
bioRxiv - Developmental Biology 2022Quote: ... and GM6001 (Illomastat; CAS: 142880-36-2; Tocris, Bristol, UK) were used ...
-
bioRxiv - Neuroscience 2022Quote: ... 2 μM apilimod dimesylate (Tocris, ref. #7283, batch 1A/257560), 50 μM camostat mesylate (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... 2 μl 20% Pluronic F-127 in DMSO (Tocris Biosciences), and 1 μl 0.5% Kolliphor EL (Sigma-Aldrich ...
-
bioRxiv - Biophysics 2023Quote: Stocks of the kinase inhibitors MLi-2 (10 mM; Tocris) and GZD-824 (10 mM ...
-
bioRxiv - Biophysics 2024Quote: ... followed by supplementation with 2 µM IWP2 (Tocris, Bristol, UK) and 10 µM SB431542 for another 24 h ...
-
bioRxiv - Cell Biology 2023Quote: ... Cells were pre-treated with MLi-2 (5756/10, Tocris) at 100 nM for 2 hours and all subsequent treatments were performed in the presence of MLi-2 ...
-
bioRxiv - Physiology 2024Quote: ... injected with 2 mg/kg acylated rat ghrelin (1465, Tocris) solubilized in PBS using an injection volume of 2 mL/kg body weight ...
-
bioRxiv - Cell Biology 2024Quote: ... EIPA (1154-25-2) was obtained from Tocris (Bristol, UK); a protease inhibitor cocktail (04,693,159,001 ...
-
bioRxiv - Developmental Biology 2021Quote: ... NMP differentiation medium was supplemented with and 5 μM Y-27632 (Tocris).
-
bioRxiv - Immunology 2019Quote: Cells were pre-treated with ML130 (5 μM; CID-1088438; Tocris, UK) 21 ...
-
bioRxiv - Cell Biology 2021Quote: Cells were treated with the actin inhibitor Cytochalasin-D (5 μM, Tocris), the Ezrin Inhibitor NSC668394 (50 μM ...
-
bioRxiv - Developmental Biology 2022Quote: ... cells were refreshed with BPEL supplemented with 5 μM XAV939 (Tocris Bioscience) and 50 ng/ml VEGF (R&D Systems) ...
-
bioRxiv - Physiology 2021Quote: ... SN-401 (DCPIB, 5 mg/kg of body weight/day, Tocris, D1540), SN-403 ...
-
bioRxiv - Developmental Biology 2021Quote: ... for 48 h followed by treatment with IWP2 (5 μM, Tocris, #3533) for an additional 48 h ...
-
bioRxiv - Cell Biology 2020Quote: ... media was changed to R/B-supplemented with 5 uM IWP2 (Tocris) for 48 hours ...
-
bioRxiv - Bioengineering 2022Quote: ... and Nodal/Activin inhibitor (SB431542, Tocris, 1614, 5 µM, days 1-10). On day 2 ...
-
bioRxiv - Neuroscience 2022Quote: ... 20 μM CNQX and 5 μM 5,7-DiCl-kynurenic acid (Tocris, UK). For whole-cell GABAR-mediated currents ...
-
bioRxiv - Neuroscience 2023Quote: ... was used to block GluN2A and ifenprodil (5 µM, Tocris, Cat#0545) was used to block GluN2B ...